AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
32.75
-1.28 (-3.76%)
Nov 4, 2025, 4:00 PM EST - Market closed
AtriCure Employees
AtriCure had 1,300 employees as of December 31, 2024. The number of employees increased by 100 or 8.33% compared to the previous year.
Employees
1,300
Change (1Y)
100
Growth (1Y)
8.33%
Revenue / Employee
$398,696
Profits / Employee
-$22,132
Market Cap
1.63B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,300 | 100 | 8.33% |
| Dec 31, 2023 | 1,200 | 150 | 14.29% |
| Dec 31, 2022 | 1,050 | 175 | 20.00% |
| Dec 31, 2021 | 875 | 125 | 16.67% |
| Dec 31, 2020 | 750 | 20 | 2.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ATRC News
- 6 days ago - AtriCure, Inc. (ATRC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025 - Business Wire
- 8 days ago - AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial - Business Wire
- 9 days ago - AtriCure to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - AtriCure to Announce Third Quarter 2025 Financial Results - Business Wire
- 2 months ago - AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation - Business Wire
- 2 months ago - AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference - Business Wire
- 3 months ago - AtriCure, Inc. (ATRC) Q2 2025 Earnings Call Transcript - Seeking Alpha